All PlansCoverageMedium impact
Avoid the Inappropriate Use of Antipsychotic Medication in Anxiety Disorders
BCBS Oklahoma·OK · Psychiatry, Family Medicine, Internal Medicine +1 more·General
Effective date
Jan 14, 2026
We identified it
Jun 19, 2026
Summary
Blue Cross Blue Shield Oklahoma issued guidance discouraging inappropriate use of antipsychotic medications for anxiety disorders, as most antipsychotics aren't FDA-approved for panic disorder or generalized anxiety disorder. The policy emphasizes evidence-based treatment guidelines and includes quality measures for metabolic monitoring when antipsychotics are prescribed.
Action Required
By January 14, 2026: Providers prescribing antipsychotic medications for anxiety disorders must ensure thorough documentation of symptom assessment, risk-benefit analysis, and medical necessity justification. Billing team should verify that claims for antipsychotic medications include appropriate anxiety disorder diagnoses and supporting documentation to avoid potential claim reviews or denials.